Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis

Principles for designing future regimens for multidrug-resistant tuberculosis

(2014) Grania Brigden et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Tuberculosis

(2014) Yong-Soo Kwon et al.   CURRENT OPINION IN PULMONARY MEDICINE

Delamanid

(2014) C. Reviriego   DRUGS OF THE FUTURE

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

(2014) C. Lange et al.   EUROPEAN RESPIRATORY JOURNAL

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

(2014) Alimuddin I Zumla et al.   LANCET INFECTIOUS DISEASES

Extensively drug-resistant tuberculosis: epidemiology and management

(2014) Alberto Matteelli et al.   Clinical Epidemiology

Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China

(2013) Qing Zhang et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Pipeline of drugs for related diseases

(2013) Kelly E. Dooley et al.   Current Opinion in HIV and AIDS

Delamanid, a new 6-nitro-2,3-dihydroimidazo[2,1-b]oxazole for the management of tuberculosis resistant to at least isoniazid and rifampicin

(2013) Andreas H Diacon et al.   Expert Opinion on Orphan Drugs

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

(2012) Vija Skripconoka et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

(2011) A. H. Diacon et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

(2008) J. van den Boogaard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents

(2008) J. G. Hurdle et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY